Dr. Christopher James Carnabatu, MD

Dr. Carnabatu practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Dr. Carnabatu's NPI, 1225532591, was assigned on March 21, 2018. Dr. Carnabatu graduated from Tulane School of Medicine in 2018. Dr. Carnabatu holds Texas license U3175.

Dr. Carnabatu's primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Dr. Carnabatu's primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. Dr. Carnabatu is also affiliated with The University of Tennessee Medical Center. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Carnabatu to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carnabatu practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Carnabatu's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Carnabatu is board certified in surgery by the American Board of Surgery. Dr. Carnabatu is licensed in Texas.

CMS data shows 18 Medicare services from Dr. Carnabatu across 1 procedure code in 2024, for 44 Medicare patients. Medicare paid $2,163 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 44 Medicare patients who saw Dr. Carnabatu in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Carnabatu's median patient age at 56, with 57% women.

In 2024, Dr. Carnabatu wrote 21 Medicare Part D claims for 12 patients. 81% of them were for generic drugs. They cover 1 drug, with $21 in total drug cost. In 2021, CMS named 64 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Carnabatu for performance year 2024, reported as part of a group. Dr. Carnabatu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Carnabatu as offering telehealth.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Carnabatu, published from 2022 to 2024. 2022 was the busiest year, with 3. Dr. Carnabatu's most frequent co-authors are Mohamed Abdelkarim Aboueisha, MD, John Wilder Baker, MD and Yusef Jalil Buti, MD.

CMS Open Payments shows 36 general payments to Dr. Carnabatu from 11 drug and device companies from 2021 to 2025. Travel and lodging make up the largest share, 51% of the total. Medtronic, Inc. paid the most, $2,567.

Dr. Carnabatu graduated from Tulane School of Medicine in 2018.

Dr. Carnabatu is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.